Cancer Therapeutics (CT) Program
The overarching goals of the Cancer Therapeutics (CT) program are to advance the translation of ideas through: 1) the development and translation of new therapeutic agents; 2) biotechnology approaches (i.e., new therapies or drug-delivery vehicles, innovative imaging technologies, and data analysis systems) to enhance new cancer treatments and diagnostics; and 3) to develop and initiate innovative clinical trials with focus on priority cancers.
The thematic areas and specific aims of the CT Program are:
- Drug Development and Delivery: To foster the development and translation of new therapeutic agents.
- Biotechnology: To utilize biotechnology to develop new cancer treatments and diagnostics.
- Developmental Therapeutics: To develop and initiate innovative clinical trials with a focus on priority cancers.
- Lacey McNally, PhD Program Co-Leader
-
Kathleen Moore, MD
Program Co-Leader
Explore Supportive Care services for your cancer journey
Learn More
Find out if you’re at risk for diabetes
Learn More
See what our commitment to ending diabetes in this century means for you
Learn More
-
OU College of Medicine Researchers Make Discovery Crucial to Treatment of Brain Cancer
The news is rarely good for people diagnosed with glioblastoma, an aggressive brain cancer that is difficult to treat and rarely is cured. However, ...
Read More -
Earn Money Using Your Mobile Device to Quit Smoking
Darla Kendzor, Ph.D. , Co-Director of the TSET Health Promotion Research Center (HPRC), wants to help those who would like to quit smoking but may ...
Read More -
OU Health Announces Chief Administrative Officer of Children’s Services
OU Health, Oklahoma’s only integrated, comprehensive academic health system, has named Kendal Pinkston chief administrative officer of children’s ...
Read More